Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Farmers Insurance
Chubb
Chinese Patent Office
Baxter
Medtronic

Generated: June 25, 2019

DrugPatentWatch Database Preview

TERAZOSIN HYDROCHLORIDE Drug Profile

Try a free trialSee Plans and Pricing

« Back to Dashboard

Which patents cover Terazosin Hydrochloride, and what generic alternatives are available?

Terazosin Hydrochloride is a drug marketed by Apotex, Beximco Pharms Usa, Heritage Pharma, Jubilant Cadista, Mylan, Mylan Technologies, Ranbaxy Labs Ltd, Sandoz, Ivax Sub Teva Pharms, and Teva. and is included in twelve NDAs.

The generic ingredient in TERAZOSIN HYDROCHLORIDE is terazosin hydrochloride. There are twenty-four drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the terazosin hydrochloride profile page.

Drug patent expirations by year for TERAZOSIN HYDROCHLORIDE
Pharmacology for TERAZOSIN HYDROCHLORIDE
Synonyms for TERAZOSIN HYDROCHLORIDE
(4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(tetrahydrofuran-2-yl)methanone hydrochloride
[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-tetrahydrofuran-2-yl-methanone hydrochloride
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone hydrochloride
074T088
1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)-piperazine hydrochloride
1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonxyl]piperazine Hydrochloride
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-piperazine hydrochloride
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride
2[4-(Tetrahydro-2-furoy1)piperazinyl]-4-amino-6,7-dimethoxyquinazoline hydrochloride
4-Amino-6,7-dimethoxy-2-[4-(tetrahydro-2-furoyl)-1-piperazinyl]quinazoline Hydrochloride
6,7-dimethoxy-2-[4-(oxolane-2-carbonyl)piperazin-1-yl]quinazolin-4-amine hydrochloride
63074-08-8
63590-64-7 (Parent)
A-45975
AB1009460
AB2000463
Abbott-45975
AC-2074
AC1L2BPY
AK307521
AKOS007930686
AN-14324
BCP12795
C19H25N5O4.HCl
CAS-63074-08-8
CCG-220751
CHEMBL1256665
DB-018541
DS-11401
DSSTox_CID_25493
DSSTox_GSID_45493
DSSTox_RID_80913
DTXSID7045493
EU-0101138
FT-0605647
HMS1570G04
Hytrin
I06-0651
IWSWDOUXSCRCKW-UHFFFAOYSA-N
KS-00000JKM
LP01138
LS-110235
MLS000040261
MLS001077301
MLS001305722
MolPort-003-666-790
NCGC00016026-10
NCGC00016903-01
NCGC00094404-01
NCGC00094404-02
NE45355
NSC-759168
NSC759168
Opera_ID_398
Pharmakon1600-01505576
Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)-, monohydrochloride
Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)-,monohydrochloride
Prestwick_146
s4679
SCHEMBL41545
SMR000044015
SR-01000000197
SR-01000000197-12
SR-01000000197-2
SR-01000000197-4
T 4680
Terazosin HCl
TERAZOSIN HYDROCHLORIDE (anhydrous)
Terazosin hydrochloride anhydrous
Terazosin hydrochloride, >=98% (TLC), powder
Terazosin hydrochloride,pharma
terazosine hydrochloride
Tetrazosin hydrochloride
TL8004930
Tox21_110674
Tox21_110674_1
TR-037527
TRA0127916
V1531
VA11840
Vasocard
Zayasel

US Patents and Regulatory Information for TERAZOSIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz TERAZOSIN HYDROCHLORIDE terazosin hydrochloride TABLET;ORAL 074315-003 Dec 31, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 074823-004 Mar 30, 1998 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva TERAZOSIN HYDROCHLORIDE terazosin hydrochloride TABLET;ORAL 074446-001 May 18, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ranbaxy Labs Ltd TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 076021-004 Aug 22, 2002 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
AstraZeneca
Harvard Business School
Express Scripts
US Department of Justice
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.